ABNORMAL-BEHAVIOR OF PROTEIN-KINASE-C IN THE HUMAN MYELOMA CELL-LINE, RPMI-8226

被引:6
|
作者
PARANT, MR
KLEIN, B
VIAL, H
机构
[1] UNIV MONTPELLIER 2,CNRS INTERACT MEMBRANAIRES,URA 530,CASE 107,PL EUGENE BATAILLON,F-34095 MONTPELLIER 5,FRANCE
[2] INSERM,F-34100 MONTPELLIER,FRANCE
关键词
B lymphocyte; Myeloma cell line; Protein kinase C; RPMI; 8226;
D O I
10.1016/0014-5793(90)81187-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase C activity of the human myeloma cell line, RPMI 8226, was studied after prepurification on DEAE-cellulose. The total protein kinase activity, eluted at 0.12 M NaCl, was 493 nmol min10 cells, but 38% was associated with membranes. The lipid dependence of cytosolic and membrane activities was only 52% and 21%, respectively. This activity increased with time, to as much as 200% for the membrane fraction after 7 days, whereas lipid dependence and the PDBu binding properties were lost. This modified activity was not due to the extinction of a copurifying endogenous inhibitor nor to classical PKC proteolysis. TPA-treatment of these eels is accompanied by a rapid, selective and complete loss of lipid-dependent activity of the cytosol, thus benefiting co-migrating lipid independent activity, with no membrane fraction recovery or PKM formation. © 1990.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [1] RPMI-8226, A HUMAN MYELOMA CELL-LINE - AN UPDATE
    MOORE, GE
    HARBELL, JW
    WOODS, LK
    MORGAN, RT
    SEMPLE, TU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 33 - 33
  • [2] ACTIVATION OF MURINE T-LYMPHOMAS IN THE PRESENCE OF A HUMAN MYELOMA CELL-LINE, RPMI-8226, INVIVO
    MILLAR, BC
    MILLAR, JL
    JONES, A
    FEARY, SW
    ROBERTSON, D
    BELL, JBG
    BRITISH JOURNAL OF CANCER, 1988, 57 (03) : 290 - 292
  • [3] CELL-CYCLE ARREST AND DNA DAMAGE AFTER MELPHALAN TREATMENT OF THE HUMAN MYELOMA CELL-LINE RPMI-8226
    FERNBERG, JO
    LEWENSOHN, R
    SKOG, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (03) : 161 - 167
  • [4] The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line
    Adamczuk, Grzegorz
    Humeniuk, Ewelina
    Iwan, Magdalena
    Natorska-Chomicka, Dorota
    Adamczuk, Kamila
    Korga-Plewko, Agnieszka
    MOLECULES, 2021, 26 (18):
  • [5] INSULIN AND IGF-1 INCREASE MITOGENESIS AND GLUCOSE-METABOLISM IN THE MULTIPLE-MYELOMA CELL-LINE, RPMI-8226
    FREUND, GG
    KULAS, DT
    MOONEY, RA
    JOURNAL OF IMMUNOLOGY, 1993, 151 (04): : 1811 - 1820
  • [6] PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR MEDIATED MODULATION OF THE HUMAN MYELOMA CELL-LINE RPMI-8226
    ROSSI, JF
    DURIE, BGM
    DUPERRAY, C
    BRAICH, T
    MARION, SL
    PIKE, JW
    HAUSSLER, MR
    JANBON, C
    BATAILLE, R
    CANCER RESEARCH, 1988, 48 (05) : 1213 - 1216
  • [7] ACTIVATION PATHWAYS TRIGGERED BY INTERLEUKIN-4 IN THE HUMAN PLASMACYTOMA CELL-LINE RPMI-8226 - DIFFERENCES WITH RESTING B-LYMPHOCYTES
    LASFAR, A
    AMIRAND, C
    BALLINI, JP
    KOLB, JP
    EUROPEAN CYTOKINE NETWORK, 1993, 4 (03) : 213 - 221
  • [8] APOPTOSIS INDUCED BY PROTEIN-KINASE-C INHIBITION IN A NEUROBLASTOMA CELL-LINE
    BEHRENS, MM
    MARTINEZ, JL
    MORATILLA, C
    RENART, J
    CELL GROWTH & DIFFERENTIATION, 1995, 6 (11): : 1375 - 1380
  • [9] Lenalidomide affect expression level of cereblon protein in multiple myeloma cell line RPMI8226
    Yang, D. Y.
    Ren, J. H.
    Guo, X. N.
    Guo, X. L.
    Cai, X. Y.
    Guo, X. F.
    Zhang, J. N.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13588 - 13594
  • [10] A PROTEIN-KINASE-C INHIBITORY ACTIVITY IS PRESENT IN THE HUMAN T-LYMPHOBLAST CELL-LINE JURKAT
    COLUMELLI, S
    HOULLIER, AM
    PERIGNON, JL
    IMMUNOLOGY LETTERS, 1991, 30 (03) : 297 - 300